3,4-dihydroxyphenylacetic acid has been researched along with Cushing Syndrome in 1 studies
3,4-Dihydroxyphenylacetic Acid: A deaminated metabolite of LEVODOPA.
(3,4-dihydroxyphenyl)acetic acid : A dihydroxyphenylacetic acid having the two hydroxy substituents located at the 3- and 4-positions. It is a metabolite of dopamine.
dihydroxyphenylacetic acid : A dihydroxy monocarboxylic acid consisting of phenylacetic acid having two phenolic hydroxy substituents.
Cushing Syndrome: A condition caused by prolonged exposure to excess levels of cortisol (HYDROCORTISONE) or other GLUCOCORTICOIDS from endogenous or exogenous sources. It is characterized by upper body OBESITY; OSTEOPOROSIS; HYPERTENSION; DIABETES MELLITUS; HIRSUTISM; AMENORRHEA; and excess body fluid. Endogenous Cushing syndrome or spontaneous hypercortisolism is divided into two groups, those due to an excess of ADRENOCORTICOTROPIN and those that are ACTH-independent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Millington, WR | 1 |
| Dybdal, NO | 1 |
| Dawson, R | 1 |
| Manzini, C | 1 |
| Mueller, GP | 1 |
1 other study available for 3,4-dihydroxyphenylacetic acid and Cushing Syndrome
| Article | Year |
|---|---|
Equine Cushing's disease: differential regulation of beta-endorphin processing in tumors of the intermediate pituitary.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; beta-Endorphin; Cushing Syndrome; Dopamine; Female; Horse D | 1988 |